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Human Keratinocyte Toll-like 
Receptors Promote Distinct Immune 
Responses
Lloyd S. Miller1 and Robert L. Modlin1,2
It has been well established that Toll-like receptors (TLRs) are expressed by kera-
tinocytes and respond to their respective ligands to initiate immune responses. 
However, it appears that keratinocytes, via differential activation of TLRs, may play 
a key role in determining the type of subsequent cutaneous immune response 
generated against a particular pathogen.
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Human Toll-like receptors (TLRs, num-
bered 1–10) are found on a variety of 
different cell types and can recognize 
various components of microorgan-
isms, subsequently initiating signaling 
pathways important in the generation 
of cytokines, chemokines, antimicrobial 
peptides, and upregulation of adhesion 
and costimulatory molecules involved in 
innate and acquired immune responses 
(Kaisho and Akira, 2006). Previous stud-
ies have demonstrated that human kera-
tinocytes express TLRs 1–6 and 9 (Kawai 
et al., 2002; Mempel et al., 2003; Song 
et al., 2002; Pivarcsi et al., 2003; Baker 
et al., 2003; Miller et al., 2005; Kollisch 
et al., 2005). In addition, some of these 
studies have demonstrated that TLRs 
on keratinocytes are functional and 
respond to their respective ligands to 
produce cytokines, and chemokines, 
and to activate NF-κB. For example, 
several studies have reported that TLR2 
and TLR4 are expressed by human kera-
tinocytes and can be activated by their 
ligands, bacterial lipopeptides and lipo-
polysaccharide, respectively (Kawai et 
al., 2002; Mempel et al., 2003; Song et 
al., 2002; Pivarcsi et al., 2003; Kollisch 
et al., 2005). Furthermore, additional 
studies have demonstrated that TLR3 
and TLR5 are also expressed by human 
keratinocytes and can be activated by 
their ligands, double-stranded RNA 
(poly-I:C) and bacterial flagellin, respec-
tively (Dai et al., 2006; Baker et al., 
2003; Miller et al., 2005; Kollisch et al., 
2005). Lastly, previous studies have also 
identified that human keratinocytes 
express TLR9 and can respond to CpG 
motifs of bacterial DNA (Mempel et al., 
2003; Miller et al., 2005).
Lebre et al. (2007, this issue) confirm 
previous reports demonstrating that 
human keratinocytes express certain 
TLRs, including TLRs 1–6, 9, and 10. A 
particular strength of this study is that 
the authors evaluated TLR expression 
and activation on cutaneous keratino-
cytes derived from plastic surgery skin 
specimens and not mucosa-derived 
keratinocytes from human foreskin 
specimens. Taken together, these data 
provide additional evidence that kera-
tinocytes not only act as a barrier to 
infectious microorganisms but also 
detect components of these organisms 
and initiate immune responses via acti-
vation of TLRs. However, the authors 
also demonstrate that certain immune 
responses generated by activation of 
TLRs 3, 4, 5, and 9 on keratinocytes are 
indeed distinct (summarized in Table 
1). Although activation of TLRs 3, 4, 
5, and 9 all induced expression of the 
proinflammatory cytokine tumor necro-
sis factor-α, the neutrophil chemotac-
tic factor IL-8 (CXCL8), the monocyte 
and basophil chemokine CCL2, and 
macrophage inflammatory protein-3 
(CCL20), of particular interest was the 
differential production of chemokines 
by these TLRs. Activation of TLR3 and 
TLR5 selectively induced CCL27, a 
chemokine that promotes memory T-
|
TLRs on keratinocytes 
may participate in 
immune responses and 
host defense against 
viruses and bacteria.
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cell recruitment specifically to the skin. 
Activation of TLR3 and TLR9 selective-
ly induced production of CXCL9 and 
CXCL10, which predominantly activate 
memory T cells and are associated with 
generation of T-helper type 1 immune 
responses. In addition, activation of 
TLR3 and TLR9 also induced produc-
tion of type I interferons (IFN-α and 
IFN-β), which are known to be impor-
tant in antiviral immune responses 
(Iwasaki and Medzhitov, 2004).
Lebre et al. (2007) discuss that the 
production of these chemokines dem-
onstrates that TLRs on keratinocytes 
may participate in immune responses 
and host defense against viruses and 
bacteria. However, they do not discuss 
why the different TLRs might elicit dif-
ferent production of chemokines. It is 
known that the signaling pathways of 
TLRs are not identical. For example, 
TLR1 and TLR6 can heterodimer-
ize with TLR2 to activate an adaptor 
molecule called MyD88 to initiate sig-
naling (Kaisho and Akira, 2006). In 
addition, TLRs 4, 5, 6, 7, 8, and 9 also 
use MyD88 to initiate signaling (Kaisho 
and Akira, 2006). On the other hand, 
TLR4, in addition to using MyD88, also 
uses a different adaptor molecule called 
TRIF to initiate signaling (Kaisho and 
Akira, 2006). TLR3 only uses TRIF (and 
not MyD88) to initiate signaling (Kaisho 
and Akira, 2006). Unlike MyD88, TRIF 
activates a signaling pathway involv-
ing IRF3, resulting in direct production 
of type I IFN (Kaisho and Akira, 2006). 
Perhaps the different adaptor molecules 
used by these TLRs contribute to the dif-
ferent chemokines produced by kera-
tinocytes. An alternative hypothesis is 
that the distinct immune responses gen-
erated by the different TLRs could be 
dependent on the cellular location of 
the TLRs. TLR4 and TLR5 are located on 
the surface of cells, whereas TLR3 and 
TLR9 are found in endosomes within 
the cytoplasm of cells (Kaisho and Akira, 
2006). Therefore the activation of these 
TLRs from these different cellular com-
partments may lead to distinct signaling 
pathways, resulting in differential cyto-
kine/chemokine production. In particu-
lar, in various cell types, the intracellular 
location of TLR3 and TLR9 has impli-
cated these receptors as important in 
defense against intracellular pathogens 
such as viruses and intracellular bacte-
rial infections (Kaisho and Akira, 2006; 
Iwasaki and Medzhitov, 2004). Lebre et 
al. (2007) have demonstrated that activa-
tion of these receptors by human kerati-
nocytes leads to a predominant T-helper 
type 1 immune response and to the pro-
duction of type I IFN, which have both 
been implicated in eliciting cell-medi-
ated immunity against these infections.
Overall, this study by Lebre et al. 
(2007) further enhances our knowledge 
about the expression and function of 
keratinocyte TLRs and suggests that the 
immune responses generated by differ-
ent keratinocyte TLRs are distinct. These 
distinct immune responses are likely to 
be critical in promoting different host 
defense mechanisms and inflammatory 
responses in the skin.
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Table 1. Activation of keratinocyte Toll-like receptors 3, 4, 5, and 9 results 
in differential production of cytokines and chemokines, and upregulation 
of adhesion, activation, and costimulatory molecules.
TLR3 TLR4 TLR5 TLR9
Innate immune cytokines and chemokines
TNF-α + + + +
IL-8 (CXCL8) + + + +
CCL2 + + + +
CCL20/MIP-3α + + + +
Memory T-cell chemotaxis
CCL27/CTACK + – + –
CXCL9/CXCL10 + – – +
Type I IFN + – – +
Upregulation of ICAM-1, HLA-DR, HLA-ABC, 
FasR, and CD40
+ + + –
Translocation of NF-κBp65 + + + +
FasR, Fas receptor; MIP-3α, macrophage inflammatory protein-3α; TLR, Toll-like receptor; 
TNF-α, tumor necrosis factor-α.
